In particular, it is unknown whether the concentration of soluble endoglin, a key angiogenesis inhibitor implicated in the pathogenesis of preeclampsia cardiovascular disease, hypertension and endothelial dysfunction [20], [21], [22], [23], is correlated with GFR. The gene discussed is ENG; the disease is cardiovascular disorder.